Diagnosed with lymphoma, Nick Howe was out of options before he tried CAR T-Cell therapy at Nebraska Medicine. Today, the Omaha firefighter is in remission and expecting his first baby. …
Omaha Firefighter Receives CAR T-Cell Therapy – Nebraska Medicine Read More
January 31, 2018 (HealthDay News) Single infusion provided durable remission with long-term persistence in pediatric, young adult patients A single infusion of the anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, …
Tisagenlecleucel Beneficial for Youth With Refractory B-Cell ALL Read More
Here are some links to studies that have recently come out on CAR T-Cell. These are obtainable only by a paid subscription to the journal. March 2018 Apoptotic Cells Dramatically …
Other Studies on CAR T-Cell Therapy Read More
Stephen M. Ansell, MD. PhD. and Radhakrishnan Ramchandren, MD discuss the Zuma 1 trial on pretreated large cell lymphoma. The CAR T-cell treatment showed a 60% to 70% response rates …
Investigating CAR T-Cell Therapy in Lymphoma Read More
Dr. Cohen describes what to expect in 2018 in the area of CAR T cell therapy, one of the most exciting new modalities for the treatment of multiple myeloma.
CAR-T cell therapy and what to look for in 2018 Read More
CAR T-Cell Therapy: A Viable Option? Chimeric antigen receptor (CAR) T-cell therapy is the first form of gene therapy approved in the U.S. CAR T-cell therapy works with the patient’s …
CAR T-Cell Therapy HCP Guide – CAR T-Cell Therapy’s Effect on the Healthcare System Read More
December 11, 2017 (HealthDay News) Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma Axicabtagene ciloleucel (axi-cel), an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy and …
ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas Read More
T-Cell Receptor Therapy: The Next Generation T cells are one type of lymphocyte important for the immune system to function properly. As with CAR T-cell therapy effect on hematologic cancers, …
CAR T-Cell Therapy HCP Guide – The Next Generation for T-Cell Receptor Therapy Read More
The Challenging Solid Tumor Microenvironment The challenging tumor microenvironment is another obstacle with CAR T-cell therapy of solid tumors. As reported by Newick and colleagues, significant hurdles include: Trafficking: CAR …
CAR T-Cell Therapy HCP Guide – Challenges: Car-T and Solid Tumors Read More
October 19, 2017 (Medical News Today) Immunotherapy, which activates a patient’s own immune system to attack cancer, is still a new approach to treating cancer. Researchers from the Massachusetts Institute …
‘Synthetic gene circuit’ may improve effectiveness of cancer immunotherapy Read More